Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongguan Baolijian Biotech is a biotechnology company headquartered in the Songshan Lake High-tech Zone of Dongguan, China. The company specializes in the development and production of in vitro diagnostic (IVD) reagents, biological raw materials, and rapid testing kits. Its product portfolio includes diagnostic solutions for infectious diseases, such as COVID-19 and influenza, as well as biochemical reagents for clinical chemistry. Baolijian operates advanced manufacturing facilities and provides contract development and manufacturing services (CDMO) for biological components. The company serves as a key supplier of antigens and antibodies to the broader diagnostic industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongguan Baolijian Biotech.